Search Ontology:
ChEBI

EC 1.1.1.44 (NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase) inhibitor

Term ID
CHEBI:74520
Synonyms
  • 6-phospho-D-gluconate dehydrogenase inhibitor
  • 6-phospho-D-gluconate dehydrogenase inhibitors
  • 6-phospho-D-gluconate:NADP+ 2-oxidoreductase (decarboxylating) inhibitor
  • 6-phospho-D-gluconate:NADP+ 2-oxidoreductase (decarboxylating) inhibitors
  • 6-phosphogluconate dehydrogenase (decarboxylating) inhibitor
  • 6-phosphogluconate dehydrogenase (decarboxylating) inhibitors
  • 6-phosphogluconic carboxylase inhibitor
  • 6-phosphogluconic carboxylase inhibitors
  • 6-phosphogluconic dehydrogenase inhibitor
  • 6-phosphogluconic dehydrogenase inhibitors
  • EC 1.1.1.44 (NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase) inhibitors
  • EC 1.1.1.44 inhibitor
  • EC 1.1.1.44 inhibitors
  • NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase (EC 1.1.1.44) inhibitor
  • NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase (EC 1.1.1.44) inhibitors
  • NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase inhibitor
  • NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase inhibitors
  • phosphogluconate dehydrogenase (NADP+ -dependent, decarboxylating) inhibitor
  • phosphogluconate dehydrogenase (NADP+ -dependent, decarboxylating) inhibitors
  • phosphogluconic acid dehydrogenase inhibitor
  • phosphogluconic acid dehydrogenase inhibitors
Definition
An EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor that interferes with the action of NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase (EC 1.1.1.44).
References
Ontology
ChEBI  ( EBI )
Relationships
is a type of
inverse has_role
Phenotype
Phenotype resulting from EC 1.1.1.44 (NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase) inhibitor
Phenotype where environments contain EC 1.1.1.44 (NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase) inhibitor
Phenotype modified by environments containing EC 1.1.1.44 (NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase) inhibitor
Human Disease Model